145 related articles for article (PubMed ID: 16399374)
1. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes.
Antonova O; Toncheva D; Grigorov E
J BUON; 2015; 20(6):1397-406. PubMed ID: 26854433
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.
Lacko M; Oude Ophuis MB; Peters WH; Manni JJ
Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Reszka E; Wasowicz W; Gromadzinska J
Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
[TBL] [Abstract][Full Text] [Related]
6. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk.
Huber WW; Parzefall W
Methods Enzymol; 2005; 401():307-41. PubMed ID: 16399395
[TBL] [Abstract][Full Text] [Related]
7. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
[TBL] [Abstract][Full Text] [Related]
8. Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk.
Unlü A; Ates NA; Tamer L; Ates C
Cell Biochem Funct; 2008; 26(5):643-7. PubMed ID: 18521819
[TBL] [Abstract][Full Text] [Related]
9. N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation.
Al-Buheissi SZ; Patel HR; Meinl W; Hewer A; Bryan RL; Glatt H; Miller RA; Phillips DH
Pharmacogenet Genomics; 2006 Jun; 16(6):391-9. PubMed ID: 16708048
[TBL] [Abstract][Full Text] [Related]
10. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
12. Diet, genetic polymorphisms, detoxification, and health risks.
Lampe JW
Altern Ther Health Med; 2007; 13(2):S108-11. PubMed ID: 17405687
[TBL] [Abstract][Full Text] [Related]
13. [Human drug metabolizing enzymes. II. Conjugation enzymes].
Vereczkey L; Jemnitz K; Gregus Z
Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
[TBL] [Abstract][Full Text] [Related]
14. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
Butkiewicz D; Chorazy M
Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
[TBL] [Abstract][Full Text] [Related]
15. [Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer].
Wang Y; Zheng Y
Wei Sheng Yan Jiu; 2008 Sep; 37(5):629-32. PubMed ID: 19069670
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis.
Saadat M
Cancer Sci; 2006 Jun; 97(6):505-9. PubMed ID: 16734729
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphism of glutathione-s-transferases theta1 and mu1 in lung cancer].
Dmitrieva AI; Sevost'ianova NV; Kolomiets SA; Tkachenko SB; Davydova NA; Cheremisina OV; Novitskiĭ VV
Vopr Onkol; 2007; 53(6):660-3. PubMed ID: 18416133
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes.
Sabbioni G; Jones CR; Sepai O; Hirvonen A; Norppa H; Järventaus H; Glatt H; Pomplun D; Yan H; Brooks LR; Warren SH; Demarini DM; Liu YY
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):559-66. PubMed ID: 16537716
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.
Sparks R; Ulrich CM; Bigler J; Tworoger SS; Yasui Y; Rajan KB; Porter P; Stanczyk FZ; Ballard-Barbash R; Yuan X; Lin MG; McVarish L; Aiello EJ; McTiernan A
Breast Cancer Res; 2004; 6(5):R488-98. PubMed ID: 15318931
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
Oude Ophuis MB; Manni JJ; Peters WH
Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
